201 results on '"Stoové, Mark A."'
Search Results
2. People in community corrections are a population with unmet need for viral hepatitis care
3. Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020
4. Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020
5. Characterizing Socioecological Markers of Differentiated HIV Risk Among Men Who Have Sex with Men in Indonesia
6. Parents who inject drugs: Demographics, care arrangements and correlates for child placement in out‐of‐home care
7. Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing
8. Prevalence and incidence of emergency department presentations and hospital separations with injecting-related infections in a longitudinal cohort of people who inject drugs
9. Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners
10. Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! Audit
11. Experiences of Kinship and Connection to Family for Aboriginal and Torres Strait Islander Young Men with Histories of Incarceration
12. Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis
13. Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis
14. Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study
15. The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
16. Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia
17. Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia
18. Substance Use After Release from Prison
19. The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia
20. Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs (PIEDs): The PUSH! Audit
21. HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study
22. The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea: a pragmatic, cluster-randomised, stepped-wedge, open-label trial
23. Engaging with communities to encourage adoption of a harm reduction approach to COVID-19
24. Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study
25. Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis
26. Assessment of a primary care e-support package of automated case finding, simplified treatment algorithm and decision support to increase hepatitis B treatment uptake in primary care clinics in Australia (SIMPLY-B Study): protocol for a pilot evaluation
27. Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia
28. Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia
29. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019
30. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data
31. Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis
32. Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis
33. Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions
34. Assessment of the lifetime prevalence and incidence of induced abortion and correlates among female sex workers in Mombasa, Kenya: a secondary cohort analysis
35. Reflections on the in-prison recruitment and participation of men with a history of injecting drug use, in a longitudinal cohort study in Australia
36. Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia
37. The impact of COVID-19 on public health systems in the Pacific Island Countries and Territories
38. Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward
39. Are there additional adverse effects of testosterone use among men living with HIV ?—Data from the PUSH ! study
40. Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study
41. High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment
42. Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020
43. Criminal Justice Involvement after Release from Prison following Exposure to Community Mental Health Services among People Who Use Illicit Drugs and Have Mental Illness: a Systematic Review
44. Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020
45. The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study
46. Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study
47. Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol
48. Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison
49. Intent to Be Vaccinated against COVID-19 in Victoria, Australia
50. Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.